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The production of TF by neutrophils and their contribution in thrombosis was until
recently a matter of scientific debate. Experimental data suggested the de novo TF
production by neutrophils under inflammatory stimuli, while others proposed that these
cells acquired microparticle-derived TF. Recent experimental evidence revealed the critical
role of neutrophils in thrombotic events. Neutrophil derived TF has been implicated in this
process in several human and animal models. Additionally, neutrophil extracellular trap
(NET) release has emerged as a major contributor in neutrophil-driven thrombogenicity
in disease models including sepsis, deep venous thrombosis, and malignancy. It is
suggested that NETs provide the scaffold for fibrin deposition and platelet entrapment and
subsequent activation. The recently reported autophagy-dependent extracellular delivery
of TF in NETs further supports the involvement of neutrophils in thrombosis. Herein, we
seek to review novel data regarding the role of neutrophils in thrombosis, emphasizing the
implication of TF and NETs.
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HISTORICAL INTRODUCTION
The role of neutrophils in the interface between inflammation
and thrombosis remains a controversial scientific issue. Even
though there is significant evidence that suggests a critical role
for neutrophils in the thrombotic process (Lerner et al., 1971),
their impact on thrombogenesis was until recently questioned.
The ability of neutrophils to enhance or trigger in vivo throm-
botic events via production and expression tissue factor (TF), the
major in vivo initiator of coagulation (Rapaport and Rao, 1995;
Bächli, 2000), is a matter of debate. During the past decade, exper-
imental evidence using not physiologic inflammatory conditions
reinforced the view that neutrophils acquire rather than produce
TF (Osterud et al., 2000; Egorina et al., 2008). As a result, the
significance of this cell population in thrombosis was considered
minor and the study of neutrophils was not included in research
models of thrombosis.
During the last few years several studies elucidated the crucial
role of neutrophils in thrombosis (Looney et al., 2006; Zernecke
et al., 2008; Darbousset et al., 2012; von Brühl et al., 2012).
Neutrophil depletion was shown to be able to reverse in vivo
experimental thrombosis, thus supporting the significance of this
population (von Brühl et al., 2012). Several studies support the
in vivo and ex vivo TF production by neutrophils (Maugeri et al.,
2006; Ritis et al., 2006; Redecha et al., 2007, 2008; Kambas et al.,
2008; Rafail et al., 2008; Kourtzelis et al., 2010).
The description of neutrophil extracellular trap (NET) release
by neutrophils revealed a novel inflammatory role of these cells
(Brinkmann et al., 2004; Clark et al., 2007; Fuchs et al., 2007;
Medina, 2009; Mitroulis et al., 2011). Moreover, recent experi-
mental data regarding the bridging of autophagy with neutrophils
and immunity (Mitroulis et al., 2010), added a novel view on
their functions. The implication of autophagy in NET release and
TF delivery to NETs and the linkage between NETs and throm-
bosis suggest a critical role for neutrophils in the interaction
between inflammatory and thrombotic pathways. Moreover, the
attenuation of thrombotic manifestations in thrombotic animal
models by neutrophil depletion demonstrates the contribution of
these cells in thrombosis (von Brühl et al., 2012). The expression
of produced and/or acquired TF by neutrophils is an attractive
and realistic scenario for the pathogenesis of thrombotic events
that characterize several inflammatory disorders, including sep-
sis (Aras et al., 2004), ANCA-associated vasculitis and Behçet’s
disease (Tomasson et al., 2009), or inflammatory bowel disease
(Miehsler et al., 2004).
TF: THE ORCHESTRATOR OF COAGULATION
TF is a 47 kDa transmembrane glycoprotein that shares high
homology in secondary and tertiary structure with interferon γ
receptors and is a member of the human class II cytokine recep-
tor family (Bazan, 1990). Currently, TF is considered as the main
in vivo initiator of coagulation (Rapaport and Rao, 1995; Bächli,
2000; Manly et al., 2011). The presence of a multitude of bind-
ing sites in the gene’s promoter region indicates multi-potency
of expression in a large variety of cells and under a vast array of
stimuli. Under normal conditions TF is not expressed in endothe-
lial cells (Wilcox et al., 1989), but only in sub-endothelial tissue,
thus creating a protecting envelope between blood and sites of
expression (Drake et al., 1989; Fleck et al., 1990). However, under
specific inflammatory conditions TF is expressed in endothe-
lial cells and myeloid leukocytes (Parry and Mackman, 1995;
Armesilla et al., 1999; Maugeri et al., 2006; Ritis et al., 2006;
Kambas et al., 2008; Rafail et al., 2008; Kourtzelis et al., 2010).
There is emerging evidence indicating the presence of circu-
lating TF in blood (blood-borne TF). There are three potential
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sources of blood-borne TF—peripheral blood cells (Drake et al.,
1989; Ritis et al., 2006; Kambas et al., 2008; Kourtzelis et al.,
2010), microparticles (MPs) (Mallat et al., 2000) and the sol-
uble alternative spliced variant of TF (Bogdanov et al., 2003).
Although monocytes have been reported to constitutively express
TF and while this cell population is considered the main source
of TF-bearing MPs (Aleman et al., 2011), there are emerging evi-
dence indicating the possible implication of other cell populations
in the generation of blood-borne TF.
Intraluminal exposure of TF located on a serine-rich phos-
pholipid membrane activates FVII, forming TF/FVIIa complex
(Bach, 1988). This complex is able to activate FX, which in turn
results in thrombin, which is responsible for thrombus stabiliza-
tion (Monroe et al., 2002). Moreover, membrane-embedded TF
is usually in inactive coagulant state (cryptic) while it requires
activation to reach its full potency (decryption) (Rao et al.,
2012). However, the mechanism behind the activation of cir-
culating TF is not yet elucidated and such information would
provide a significant breakthrough in the understanding of in vivo
thrombosis.
Nevertheless, apart from the role of the extrinsic coagula-
tion system (TF—thrombin axis) in thrombosis, this system
has been implicated in several non-thrombotic models such as
angiogenesis, tumor growth and metastasis, inflammation, and
fibrosis. The serine proteases of this pathway, namely TF/VIIa,
Xa, and thrombin, are able to signal through the protease
activated receptor (PAR) receptor family to produce intracel-
lular signals (Coughlin, 2005) via phosphoinositide 3-kinase
(PI3K), Src tyrosine kinase, extracellular signal-regulated kinase
(ERK), and mitogen-activated protein kinase (MAPK) pathways
(Ramachandran and Hollenberg, 2008). The activation of these
pathways results in the secretion of cytokines and chemokines
implicated in several biological functions (Coughlin, 2005).
INFLAMMATION AND THROMBOSIS: A RECIPROCAL
PROCESS
Increased prevalence of venous thrombotic events is a long
standing observation in patients suffering from infectious and
sterile inflammatory disorders. Venous thrombosis constitutes
a major morbidity and mortality factor in inflammatory dis-
eases, including sepsis, systemic lupus erythematosus (SLE),
inflammatory bowel disease, or vasculitis (Zöller et al., 2012).
Additionally, recent clinical data derived from patients with
rheumatoid arthritis and SLE support the critical role of
inflammation in accelerated atherothrombosis (Santos et al.,
2012). Experimental evidence links the observed thrombogenic-
ity with TF-dependent activation of extrinsic coagulation cascade.
Increased TF expression by endothelial and blood cells exposed
to inflammatory mediators is proposed as an essential part of
the pathogenic mechanism for arterial and venous thromboem-
bolism that characterizes inflammatory disorders (Mackman,
2009). These observations indicate a potential triggering role of
inflammation in thrombosis. However, the relationship between
inflammation and thrombosis is bidirectional since thrombo-
sis can reignite inflammation creating a persistent or recur-
rent inflammatory environment. TF-thrombin axis enhances the
inflammatory response in several clinical models such as arthritis
(Busso et al., 2003), antiphospholipid syndrome (APS) (Ritis
et al., 2006; Redecha et al., 2007, 2008), ischemia/reperfusion
injury (Loubele et al., 2009), and sepsis (Osterud and Bjorklid,
2001; Aras et al., 2004;Wang et al., 2009). Signaling through PARs
plays a critical role for this reciprocal process. TF:FVIIa com-
plex has been implicated in the induction of inflammation in
the aforementioned clinical models. In an endotoxemic animal
model, both TF deficiency and combined inhibition of thrombin
and deficiency in PAR2 reduced inflammation (Pawlinski et al.,
2004). Further studies in animal models of sepsis demonstrated
that extrinsic coagulation cascade inhibition with a varying range
of anticoagulants [natural anticoagulants, Tissue Factor Pathway
Inhibitor (TFPI), Protein C, and Antithrombin III] attenu-
ated the persisting inflammation (Taylor et al., 1987, 1998a,b;
Ramachandran and Hollenberg, 2008). Moreover, it has been
recently shown that thrombin is able to generate biologically
active C5a from C5 in the absence of C3, indicating a significant
role in the reignition of inflammation (Huber-Lang et al., 2006;
Krisinger et al., 2012). However, the physiological contribution of
this pathway has to be further investigated. This data establish the
reciprocal and close relationship between the two systems.
TF PRODUCTION BY NEUTROPHILS: A CONTROVERSIAL ISSUE
The expression of TF by neutrophils was initially reported almost
40 years ago (Lerner et al., 1971), although those studies did
not include solid proof on their ability to produce TF protein.
However, it is less than 10 years since evidence on the ability
of neutrophils to produce functional TF arose. A turning point
in the investigation of TF expression by blood cells was the
observation that the promoter of TF gene is strictly regulated by
methylation. TF promoter exists in its unmethylated form in both
monocytes and neutrophils, allowing stimuli-driven TF mRNA
transcription.
TF production by neutrophils was opposed by other reports
(Osterud, 2004, 2012). It was reported that isolated neutrophils
failed to produce TF protein when stimulated with LPS alone or
in conjunction with phorbol myristate acetate (PMA) or TNF-α
(Osterud et al., 2000). TF activity in culture supernatants was
attributed to platelet activation by contaminating monocytes
(Osterud et al., 2000). A study in an in vivo murine sepsis model
demonstrated that the cluster of TF positive cells infiltrating
the spleen were granulocytes. However, even though these cells
expressed TF protein, they did not possess TF mRNA (de Waard
et al., 2006). The authors attributed this finding to the uptake by
neutrophils of TF produced by other cell types in the form of
MPs. This was supported by a study suggesting that neutrophils
acquire monocyte-derived TF rather than synthesize it by them-
selves (Egorina et al., 2008). Using a blood reconstitution model
and cells transfected with si-RNA for TF, the authors were able
to demonstrate that only monocytes contributed in LPS-induced
TF expression. Interestingly, this TF was not localized on neu-
trophil membrane but intracellularly. Even though there is clear
evidence for the acquisition of TF by granulocytes in this article,
the authors used a limited number of mediators and conditions
for neutrophil activation.
Even though these findings indicate a mechanism for TF
transfer from monocytes to neutrophils, they do not exclude
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the possibility for TF production by neutrophils under in vivo
inflammatory conditions.
On the opposite side of the debate, it has been found that
neutrophils produce functional TF protein after stimulation with
P-selecting or N-formyl-methionyl-leucyl-phenylalanine (fMLP)
but not PMA. Interestingly, cells expressed TF intracellularly and
after stimulation with fMLP the protein was translocated to cell
membrane in a small percentage of cells (Maugeri et al., 2006).
At the same time, the ability of neutrophils to produce TF was
reported in an ex vivo human model of APS (Ritis et al., 2006).
It was shown that IgG immunoglobulin from patients with APS
triggers the activation of complement and subsequently gener-
ation of C5a. The produced anaphylatoxin was able to induce
TF gene transcription and production of active TF by human
neutrophils. These findings were verified by another study in a
murine in vivo APS model. It was demonstrated that TF respon-
sible for fetal miscarriages was derived from myeloid cells and
particularly neutrophils in a C5a-dependent manner (Redecha
et al., 2007). Blocking of TF attenuated trophoblast damage
and reduced miscarriages. The same group in a following study
in the same murine model demonstrated that TF:FVIIa com-
plex exhibits signaling through PAR2 receptor on activated neu-
trophils causing trophoblast damage and fetal death via reactive
oxygen species release (Redecha et al., 2008). Mice with dele-
tion of the cytoplasmic domain of TF, responsible for interaction
with FVIIa and consequently PAR2 receptor, or PAR2 knockout
exhibited lower neutrophil activation levels and normal preg-
nancies. Moreover, another study demonstrated the expression
of TF by neutrophils isolated from the bronchoalveolar fluid
(BALF) from patients with Acute Respiratory Distress Syndrome
(ARDS) (Kambas et al., 2008). The ability of BALF from such
patients to induce TF expression was attributed to the synergis-
tic effect of C5a and TNF-α. C5a-dependent TF production by
neutrophils was also observed in an extracorporeal circulation
model (Kourtzelis et al., 2010). It was demonstrated that serum
from End Stage Renal Disease (ESRD) patients induces func-
tional TF production in both neutrophils and monocytes from
healthy individuals in a C5a-dependent manner. Of interest, in
the same study, granulocyte colony stimulating factor (G-CSF)
levels were significantly correlated with TF expression. The signif-
icance of neutrophil priming in their activation by cytokines has
been recently described (Yousefi et al., 2009; Hattar et al., 2010).
Moreover, in vitro data supported the production of TF by neu-
trophils stimulated with leptin. Inhibition studies indicated that
TF induction was partially mediated by TNF-α and JAK2/PI3K
(Rafail et al., 2008).
Even though these data provide significant evidence for the
ability of neutrophils to produce TF, they do not answer the
question on how neutrophils can externalize TF in a func-
tional manner. New breakthroughs in neutrophil biology and
particularly the description of NETs reveal possible solutions
to unwinding Ariadne’s thread regarding this debatable issue
(Table 1).
A CRITICAL ROLE OF NEUTROPHILS IN THROMBOSIS
Despite the debate whether neutrophils are able to produce TF
or not, there are several articles demonstrating their active role
in in vivo experimental thrombosis and inflammation-driven
thrombotic diseases. In animalmodels of acute lung injury caused
by differential etiology, including acid aspiration (Folkesson et al.,
1995), ischemia/reperfusion (Eppinger et al., 1997), and trans-
fusion related acute lung injury (TRALI) (Looney et al., 2006),
neutrophil depletion before the initiation of inflammation atten-
uates lung injury. Furthermore, in a model of diet-induced
atherosclerosis, circulating neutrophils were required for plaque
formation in atherosclerotic lesions (Zernecke et al., 2008). An
additional contribution of neutrophils in the activation of extrin-
sic coagulation cascade is the degradation of TFPI via elastase
release (Massberg et al., 2010). TFPI is the main inhibitor of TF.
Additionally, protein disulfide isomerise, a key protein for the
activation of cytoplasmic TF (Reinhardt et al., 2008) was found
to be expressed in neutrophils (von Brühl et al., 2012). Thus,
neutrophils play an important role in the activation of extrinsic
coagulation system, either by regulating its breaks or by activating
its initiator.
Recently, Darbousset et al. (2012) clearly demonstrated that
neutrophil binding to the injured endothelium was the initial step
in the continuum of events that resulted in thrombus formation
in a model of laser-induced endothelial injury. The critical role
of neutrophils was reinforced by the observation that these cells
were the main source of TF, which was required for thrombus
formation. Additionally, in the same model, factor XII deficiency
did not attenuate thrombus generation. Another recent study in a
mouse model of deep vein thrombosis (DVT) provided evidence
for the indispensable role of neutrophils in venous thrombo-
sis, as shown by neutrophil depletion (von Brühl et al., 2012).
Neutrophils were shown to promote thrombogenesis by bind-
ing and activating factor XII, which is in contrast to the study
by Darbousset et al. using conditional mutants and bone mar-
row chimeras, the authors also demonstrated that TF derived
from myeloid cells and not endothelial cells was responsible for
the activation of coagulation system. However, monocyte-derived
TF was not sufficient for the formation of thrombus. These
well-organized studies provide convincing evidence for the sig-
nificance of neutrophils in thrombosis and mark the restoration
of neutrophils in the forefront of the investigation of thrombosis.
NETs AND THROMBOSIS
Neutrophils, as a critical part of innate immunity, have evolved
mainly around their ability to fight bacterial infections. Novel
insight on neutrophil biology demonstrated a new mechanism
of neutrophils to defend against pathogens through the release
of NETs. NETs are chromatin filaments that form a network of
DNA, histones and several cytoplasmic and granule proteins with
antibacterial or immune-modulating role (Jaillon et al., 2007;
Sangaletti et al., 2012). NETs are released as a last measure of
defence from neutrophils (Brinkmann and Zychlinsky, 2007).
Recent studies demonstrated the critical implication of NETs
in animal thrombotic models. Using a murine model of endo-
toxemia and an in vitro model of blood flow, Clark et al. (2007)
reported that the formation of NETs in the vasculature resulted
in the entrapment of platelets. Subsequent platelet activation
induced endothelial injury leading in the impairment of blood
flow. A few years later, the contribution of NETs in thrombus for-
mation was shown in a baboon DVT model (Fuchs et al., 2010).
This study demonstrated that NETs entrapped both platelets and
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erythrocytes, while NETs served as three dimensional scaffolds for
fibrin deposition and the subsequent stabilization of thrombus.
Moreover, histones were identified as the culprit for platelet acti-
vation. Another study demonstrated that neutrophils contribute
in tissue injury through NET release in a TRALI mouse model
(Caudrillier et al., 2012).More specifically, activated platelets were
able to stimulate neutrophils for NET release which increased
endothelial permeability. Moreover, inhibition of platelet activa-
tion reduced NET release and tissue injury. Pretreatment with
either histone blocking or DNase I reduced endothelial damage in
TRALI. In a murine DVT model, neutrophils were demonstrated
as a major factor of thrombosis, as shown by the effect of neu-
trophil depletion. Neutrophils were found to contribute to DVT
through NET release since treatment with DNase I suppressed
DVT growth (von Brühl et al., 2012). Citrullinated H3 histone
interaction with vonWillebrand factor was proposed as a possible
mechanism for the formation of erythrocyte rich thrombus (red
thrombus). NET formation was also observed by neutrophils in
the context of chronic myelogenous leukemia and in solid tumor
models (Demers et al., 2012). The authors correlated NET release
with cancer related thrombosis, through presence of citrulli-
nated H3 histone and high plasma DNA concentrations. Finally,
as already mentioned, NET release was associated with venous
thrombosis through factor XII activation in a murine DVTmodel
induced by partial vessel occlusion.
EXTRACELLULAR TF DELIVERY THROUGH NETs
The contribution of neutrophils in thrombosis was overshad-
owed by the debate on their ability to produce functional TF.
Additionally, the intracellular localization of TF in neutrophils
FIGURE 1 | Neutrophils release NETs decorated with TF under sepsis
conditions. (A) Neutrophils were incubated for 60 or 180min with serum
from patients with sepsis to release NETs. TF (green staining) is localized in
autophagosomes (LC3B: red staining) and in NETs, respectively. DNA
stained with DAPI (blue). Z-stack analysis. Scale bars represent 5μM. Original
magnification 1000×. (B) Schematic representation of the proposed
mechanism. Inflammatory conditions prime and stimulate neutrophils to
produce TF which is engulfed in autophagosomes and translocated on NETs.
TF coated NETs can further entrap circulating platelets to form thrombus and
trigger cell signaling through PARs.
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raised concerns regarding its ability to activate coagulation sys-
tem, since only minimal TF amounts were detected on cell
membrane.
An explanation for the extracellular delivery of neutrophil-
borne TF was the identification of TF on NETs. The first descrip-
tion of TF expression in NETs was by the study of von Brühl et al.
(2012). The authors proposed that activation of factor XII rather
than TF on NETs was not essential for thrombus formation even
though they did not investigate the role of TF present on NETs.
Recently, we demonstrated that neutrophils from patients with
sepsis release large amounts of TF in the form of NETs (Kambas
et al., 2012). NET-borne TF was able to generate thrombin,
which subsequently resulted in platelet activation. Microparticle
depletion from sepsis serum suggested the de novo TF pro-
duction and ensured that neutrophils did not acquire TF from
TF-bearing MPs of unknown origin. The observed inclusion of
TF in autophagosomes prior to its extracellular delivery in NETs
suggested the involvement of autophagy in this process. This
autophagy-dependent pathway was also shown for high-mobility
group protein B1 (HMGB-1), proposing a role for autophagy as a
secretory mechanism for the externalization of membrane bound
or cytosolic proteins to NETs. Using in vitro stimulation stud-
ies, it was shown that neutrophil priming with pro-inflammatory
cytokines is required for TF mRNA translation after bacterial
phagocytosis. These findings further demonstrate the critical role
of inflammatory mediators in the post-transcriptional regulation
of TF. Even though there are speculations that in vivoNET-bound
TF could be trapped MPs of different origin (neutrophil, platelet,
monocyte, etc.), it does not alter the crucial role of NETs in the
interplay between inflammation and thrombosis.
Based on the above findings, NETs act as mechanism for the
localized extracellular expression of intracellular epitopes and
anti-microbial proteins. These networks function as a scaffold for
thrombus formation by exposing active TF to the other serine
proteases of the extrinsic coagulation cascade. Moreover, entrap-
ment and activation of circulating platelets further contributes
in the obstruction of blood flow, while entrapped platelets pre-
vent the degradation of this scaffold by DNase. This maelstrom
of events, from neutrophil attachment to endothelium to NET
release and the subsequent thrombi formation in the microvascu-
lature could be critical in the pathophysiology of sepsis (Figure 1).
Autophagy could function as a selective transport mechanism for
the delivery of proteins to NETs. Moreover, an additional role for
autophagy in the regulation of protein levels through degradation
or even post-translation protein modification is implied.
CONCLUSION
Despite the well-established correlation between inflammation
and thrombosis in clinical practice (Aras et al., 2004; Miehsler
et al., 2004; Tomasson et al., 2009; Zöller et al., 2012), the role
of neutrophils in thrombogenicity has only recently emerged.
Growing evidence support the critical involvement of NET for-
mation in this process. Neutrophil recruitment and activation
at the site of endothelial damage is considered as the initial
event in thrombus formation. The local intralluminal exposure
of high levels of thrombogenic TF in NETs could be essential
for the initiation and propagation of both venous and arte-
rial thrombosis. Additionally, neutrophil-driven activation of the
extrinsic coagulation cascade could exert through PAR signaling
a significant contribution in non-thrombotic processes, including
inflammation, cancer biology, or fibrosis.
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